CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 68 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,754 | -25.3% | 49,421 | -0.4% | 0.04% | -26.5% |
| Q2 2023 | $85,306 | +113.9% | 49,596 | +87.8% | 0.05% | +133.3% |
| Q1 2023 | $39,884 | +0.6% | 26,412 | +6.6% | 0.02% | 0.0% |
| Q4 2022 | $39,660 | -44.1% | 24,787 | -48.2% | 0.02% | -44.7% |
| Q3 2022 | $71,000 | +6.0% | 47,869 | +33.3% | 0.04% | +18.8% |
| Q2 2022 | $67,000 | +67.5% | 35,919 | +145.3% | 0.03% | +113.3% |
| Q1 2022 | $40,000 | -35.5% | 14,644 | +6.5% | 0.02% | -28.6% |
| Q4 2021 | $62,000 | -8.8% | 13,744 | +2.6% | 0.02% | -16.0% |
| Q3 2021 | $68,000 | – | 13,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,230,898 | $40,535,000 | 5.15% |
| Opaleye Management Inc. | 450,000 | $8,176,000 | 2.89% |
| EcoR1 Capital, LLC | 829,771 | $15,077,000 | 2.01% |
| Perceptive Advisors | 2,780,762 | $50,526,000 | 0.96% |
| Casdin Capital, LLC | 177,500 | $3,225,000 | 0.91% |
| Iguana Healthcare Management, LLC | 140,000 | $2,544,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 756,822 | $13,751,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $3,816,000 | 0.54% |
| HAMILTON LANE ADVISORS LLC | 28,346 | $515,000 | 0.35% |
| Tekla Capital Management LLC | 530,092 | $9,632,000 | 0.34% |